Skip to main content
News Icon

Honors & Funding

Congratulations to the recipients of the SFB/ Transregio grants:

University of Bonn researchers were successful in the securing SFB/Transregio grants.The SFB/Transregio Aortic Diseases will be working on basic and clinical research on expanding the understanding of fundamental principles in the pathogenesis of aortic diseases. The SFB/Transregio Cellular mechanisms of antibiotic action and production intends to further investigate the biochemical production and action mechanisms of antibiotics.

Related news

Gut

Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

—The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

—The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

Honors & Funding

Precise active ingredients against pancreatic cancer

—Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry

Back to the news overview